| Views | |
|---|---|
| (1 R,3 S)-3-(1 H -Benzo[ d ]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient | 417 |
| December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | |
|---|---|---|---|---|---|---|---|
| (1 R,3 S)-3-(1 H -Benzo[ d ]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient | 6 | 8 | 9 | 5 | 6 | 12 | 9 |
| Views | |
|---|---|
| Chuev_H_Benzo.pdf | 155 |
| Views | |
|---|---|
| United States | 214 |
| Canada | 27 |
| United Kingdom | 23 |
| Germany | 19 |
| Russia | 17 |
| Vietnam | 7 |
| Romania | 5 |
| Brazil | 3 |
| China | 3 |
| Australia | 2 |
| Views | |
|---|---|
| Ottawa | 25 |
| Houston | 24 |
| San Francisco | 18 |
| Ann Arbor | 16 |
| Basking Ridge | 15 |
| Abingdon | 14 |
| Fairfield | 14 |
| Wilmington | 12 |
| Milwaukee | 8 |
| Moscow | 8 |